Delivery Order SPE2DB22D1017-SPE2DB23FG2SL
Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency awarded a $325,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lumigan 0.01% eye drops. The order is for 5 milliliter bottles of the ophthalmic solution to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this requirement supporting the DLA's medical supply needs. No subcontractors or set aside designations were identified.</p>
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,653 to Amerisourcebergen Drug Corporation for the supply of Lumigan 0.01% eye drops. To be performed in Conshohocken, Pennsylvania from July 28 through July 31, 2023, this order is issued against an existing DLA pharmaceuticals contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested ophthalmic solution...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred twenty-three thousand one hundred ten dollars to Amerisourcebergen Drug Corporation for the supply of Lumigan 0.01% eye drops. Under this contract, Amerisourcebergen will deliver 2.5mL bottles of the ophthalmic solution to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $785.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562001842 Lumigan 0.01% eye drops in 5mL bottles. To be performed from August 30 to 31, 2023 in Conshohocken, Pennsylvania, this order is likely associated with DLA's medical supply support to the Department of Defense. No major subcontractors or set aside designations were indicated. DLA manages the global supply chain for the DoD and would procure these eye drops to support...
- The Defense Logistics Agency awarded a $10,175.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for LUMIGAN 0.01% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliters of the ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by August 25, 2023 under the parent company Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $245.83 delivery order contract to Amerisourcebergen Drug Corporation to supply Lumigan 0.01% eye drops. As the prime contractor, Amerisourcebergen will deliver 7.5mL bottles of the ophthalmic solution to a location in Conshohocken, Pennsylvania by September 8, 2023 under a firm fixed price arrangement. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely contracts for pharmaceuticals and medical supplies to...
- The Defense Logistics Agency awarded a $3,202.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561772066 Lumigan 0.01% eye drops. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 10-11, 2023 is under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. As the prime and parent company, Amerisourcebergen Corporation will fulfill the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,616.96 to Amerisourcebergen Drug Corporation for the supply of 2.5ml Lumigan 0.01% eye drops. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 1...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG2SLDelivery Order
The Defense Logistics Agency awarded a $2,692.81 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 5mL bottles of Lumigan 0.01% eye drops. The eye drops will be delivered to a facility located in Conshohocken, Pennsylvania by September 5, 2023 to support DLA programs. Amerisourcebergen will serve as the prime contractor on this small business set-aside contract to provide the requested pharmaceutical products. No major subcontractors or additional context were indicated regarding DLA's use of these eye drops.
Generated 12/23/23, 3:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/1/23 |